106 results
8-K
EX-99.1
ADPT
Adaptive Biotechnologies Corp
7 May 24
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
4:15pm
Other assets
Total assets
Liabilities and shareholders’ equity
Current liabilities
Accounts payable
Accrued liabilities
Accrued compensation and benefits
8-K
ADPT
Adaptive Biotechnologies Corp
9 Apr 24
Departure of Directors or Certain Officers
5:29pm
. Piskel will receive the severance benefits provided to Executive Vice Presidents under the Company’s form of Executive Severance Agreement as described
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
9 Apr 24
Departure of Directors or Certain Officers
5:29pm
year, less applicable tax and other withholdings.
Benefits
You will not experience a change in your benefits and will continue to be eligible
8-K
EX-99.1
2p2 vcntse8q
14 Feb 24
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
4:15pm
8-K
EX-99.1
hev61r ix
9 Nov 23
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
EX-99.1
wve9nwyyi gsgli5cy
2 Aug 23
Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results
4:17pm
8-K
EX-99.1
5lk0s0qsfskk41wo6
3 May 23
Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
1unssvfyf1n9n0mmd7
3 Nov 22
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
4:16pm
8-K
EX-10.1
qt100u6yo k48xqwoj
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
8-K
EX-99.1
u47u6d
3 Aug 22
Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
4:16pm